PROQR THERAPEUTICS (Germany) Probability of Future Stock Price Finishing Under 3.27
| 0PQ Stock | EUR 3.55 0.15 4.41% |
PROQR |
PROQR THERAPEUTICS Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PROQR THERAPEUTICS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PROQR THERAPEUTICS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PROQR THERAPEUTICS is way too risky over 90 days horizon | |
| PROQR THERAPEUTICS appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.93 M. Net Loss for the year was (46.56 M) with profit before overhead, payroll, taxes, and interest of 2.4 M. | |
| PROQR THERAPEUTICS EO 04 has accumulated about 75.84 M in cash with (47.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
PROQR THERAPEUTICS Technical Analysis
PROQR THERAPEUTICS's future price can be derived by breaking down and analyzing its technical indicators over time. PROQR Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PROQR THERAPEUTICS EO 04. In general, you should focus on analyzing PROQR Stock price patterns and their correlations with different microeconomic environments and drivers.
PROQR THERAPEUTICS Predictive Forecast Models
PROQR THERAPEUTICS's time-series forecasting models is one of many PROQR THERAPEUTICS's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PROQR THERAPEUTICS's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about PROQR THERAPEUTICS
Checking the ongoing alerts about PROQR THERAPEUTICS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PROQR THERAPEUTICS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PROQR THERAPEUTICS is way too risky over 90 days horizon | |
| PROQR THERAPEUTICS appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.93 M. Net Loss for the year was (46.56 M) with profit before overhead, payroll, taxes, and interest of 2.4 M. | |
| PROQR THERAPEUTICS EO 04 has accumulated about 75.84 M in cash with (47.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
Other Information on Investing in PROQR Stock
PROQR THERAPEUTICS financial ratios help investors to determine whether PROQR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PROQR with respect to the benefits of owning PROQR THERAPEUTICS security.